Results 31 to 40 of about 163,240 (292)

The Role of Outer Membrane Protein(s) Harboring SLH/OprB-Domains in Extracellular Vesicles’ Production in Synechocystis sp. PCC 6803

open access: yesPlants, 2021
Cyanobacteria are a group of photosynthetic prokaryotes that contribute to primary production on a global scale. These microorganisms release vesicles to the extracellular environment, spherical nanosized structures, derived essentially from the outer ...
Delfim Cardoso   +4 more
doaj   +1 more source

Porphyromonas gingivalis Outer Membrane Vesicles Increase Vascular Permeability [PDF]

open access: yesJournal of Dental Research, 2020
Periodontitis is increasingly associated with increased risk of cardiovascular and other systemic diseases. The Gram-negative anaerobe, Porphyromonas gingivalis, is a key periodontal pathogen, and several lines of evidence link the presence of this bacterium in the circulation with vascular disease.
Farrugia, C.   +2 more
openaire   +4 more sources

Porphyromonas gingivalis Outer Membrane Vesicles Mediate Coaggregation and Piggybacking of Treponema denticola and Lachnoanaerobaculum saburreum

open access: yesInternational Journal of Dentistry, 2013
Porphyromonas gingivalis sheds outer membrane vesicles that contain several virulence factors, including adhesins. In this study, we investigated the ability of P.
Daniel Grenier
doaj   +1 more source

Bacterial Membrane Vesicles: Physiological Roles, Infection Immunology, and Applications

open access: yesAdvanced Science, 2023
Bacterial or fungal membrane vesicles, traditionally considered as microbial metabolic wastes, are secreted mainly from the outer membrane or cell membrane of microorganisms.
Yixiao Gan   +5 more
doaj   +1 more source

Microbial biosynthesis of designer outer membrane vesicles [PDF]

open access: yesCurrent Opinion in Biotechnology, 2014
Outer membrane vesicles (OMVs) are nanoscale proteoliposomes that are ubiquitously secreted by Gram-negative bacteria. Interest in these bioparticles has escalated over the years, leading to discoveries regarding their composition, production, and vaccine potential.
Jenny L, Baker   +4 more
openaire   +2 more sources

Engineering Planar Gram-Negative Outer Membrane Mimics Using Bacterial Outer Membrane Vesicles

open access: yesLangmuir, 2023
AbstractAntibiotic resistance is a major challenge in modern medicine. The unique double membrane structure of gram-negative bacteria limits the efficacy of many existing antibiotics and adds complexity to antibiotic development by limiting transport of antibiotics to the bacterial cytosol. New methods to mimic this barrier would enable high-throughput
Aarshi N. Singh   +4 more
openaire   +3 more sources

Identification of a synaptic vesicle-specific membrane protein with a wide distribution in neuronal and neurosecretory tissue. [PDF]

open access: yes, 1981
Two different monoclonal antibodies, characterized initially as binding synaptic terminal regions of rat brain, bind a 65,000-dalton protein, which is exposed on the outer surface of brain synaptic vesicles. Immunocytochemical experiments at the electron
Matthew, WD, Reichardt, LF, Tsavaler, L
core   +2 more sources

Outer membrane vesicles as platform vaccine technology [PDF]

open access: yesBiotechnology Journal, 2015
AbstractOuter membrane vesicles (OMVs) are released spontaneously during growth by many Gram‐negative bacteria. They present a range of surface antigens in a native conformation and have natural properties like immunogenicity, self‐adjuvation and uptake by immune cells which make them attractive for application as vaccines against pathogenic bacteria ...
van der Pol, Leo   +2 more
openaire   +2 more sources

The Proteome of Biologically Active Membrane Vesicles from Piscirickettsia salmonis LF-89 Type Strain Identifies Plasmid-Encoded Putative Toxins [PDF]

open access: yes, 2017
Indexación: Scopus.Piscirickettsia salmonis is the predominant bacterial pathogen affecting the Chilean salmonid industry. This bacterium is the etiological agent of piscirickettsiosis, a significant fish disease.
Artigues, A.   +14 more
core   +1 more source

Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine

open access: yesBrazilian Journal of Infectious Diseases, 2021
Meningococcal disease by serogroup B has been a public health problem in Brazil in the last decades. The Brazilian Oswaldo Cruz Foundation has been working to develop a vaccine with detergent-treated outer membrane vesicles (OMV) and detoxified endotoxin
R. Menezes Martins   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy